Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 12

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 12
---
 sickle cell disease or cystic fibrosis, where carrier status has been documented in each of the parents. By using this technique, 
 physicians are able to check the genes or chromosomes for a specific genetic condition. PGD can decrease the risk of miscarriage          
 and this technology can help women better achieve a healthy pregnancy. Individuals who suspect or know they carry genes for serious       
 medical conditions may opt to screen for healthy embryos ahead of time.                                                                   |

Well Established Brand with Reliable Reputation The founders of NewGenIvf entered the fertility market as agents in 2011 by introducing patients in need to a Thailand clinic for fertility treatments. The founders of NewGenIvf started to operate their own clinic in Thailand in 2014 and subsequently added clinics in Cambodia and Kyrgyzstan. Since then, NewGenIvf has attracted clients from countries throughout Asia-Pacific, including Mainland China, Hong Kong, India, Thailand, Australia and Taiwan.

<div align='center'>4</div>

NewGenIvf benefits from the
favourable geographic locations of its clinics, especially its clinic in Thailand. Located in central Bangkok and situated in one of
the biggest shopping malls of the city, the clinic is located in close proximity to various transportation facilities and popular tourist
attractions, such as the Erawan Shrine. In this regard, NewGenIvf believes that its business has benefited from, and will continue to
benefit from, the convenience of its locations.

NewGenIvf has developed a
relatively replicable and scalable operating model that supports high productivity at its assisted reproductive medical facilities in
Asia. Under this model, NewGenIvf’s medical facilities have established standardized operating procedures to select the treatment
process according to each patient’s profile. NewGenIvf’s medical and operational personnel are organized into specialized
teams according to the different stages of the treatment process and different patient profiles. When patients are initially admitted
or would like to seek additional medical services later on, they are assigned to one of the optimal medical teams, which NewGenIvf believes
is better suited after taking into account the patient’s diagnosis and preferences. NewGenIvf believes that this model allows each
team to improve its efficiency and arrange suitable physicians for patients.

The physicians of NewGenIvf
have also developed and employed an operating model that seeks to increase the effectiveness of physicians by utilizing standardized
workflows and operating procedures with teams of supporting nurses and medical assistants. This helps to increase the number of IVF treatment
cycles that physicians